When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DBVT - Aimmune: Current Lows Look Attractive But Coronavirus May Play Spoilsport
DBV Technologies S.A.
Aimmune Therapeutics (AIMT) was a stock I followed and invested in and also recommended to my subscribers before the approval. The stock did double over a period of 6 months, however, there were some jittery moments right before Palforzia’s (AR101) approval with unscheduled delays and so on. However, that is past history.
What is important now is to understand whether the current terrible crash in the stock - one that has brought it back down to below what it was when I recommended buying it - is an opportunity or a disaster.